Elsevier Announces the Departure of Fiona Foley
New York, N.Y., March 8, 2006 – Elsevier announced today that Ms. Fiona Foley has decided to leave her position as Executive Vice President of Global Medicine. Elsevier and Fiona Foley are in discussions regarding a possible consultancy role in Medical Publishing.
According to Brian Nairn, Chief Executive Officer of Elsevier Health Sciences, “Fiona has contributed greatly to the success of Elsevier during her tenure here. Her strategy and initiatives have improved our book publishing and furthered the development of our clinical medicine e-products”.
As a result of the move, Mr. Nairn has also taken the opportunity to reorganize the Global Medicine group to ensure the important relationships with Elsevier’s customers and authors continue to thrive.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.Media Contact:
Director, Corporate Relations